CXCL10 and Graves disease: In a clinical context, circulating levels of CXCL10 have been estimated to 120±83 pg ml−1 in patients diagnosed with Graves’ Disease as compared with 72±32 pg ml−1 in controls34; an average increase of 67% not taking genetic and non-genetic covariates into account.